Blood Pressure Lowering and Outcomes in type 2 Diabetes: Implications of the Blood Pressure-Lowering Arm of the Advance Trial

Publisher： Bentham Science Publishers

E-ISSN： 1875-6506|5|3|168-180

ISSN： 1573-4021

Source： Current Hypertension Reviews, Vol.5, Iss.3, 2009-01, pp. : 168-180

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pros and Cons of Aggressive Blood Pressure Lowering in Patients with Type 2 Diabetes

By  

Current Vascular Pharmacology, Vol. 10, Iss. 2, 2012-03 ,pp. : 156-161

Bentham Science Publishers

Access to resources Recommend Favorite

Hypertension and Lowering Blood Pressure

By  

Cerebrovascular Diseases, Vol. 15, Iss. 2, 2003-04 ,pp. : 19-23

Karger

Access to resources Recommend Favorite

Residual Cardiovascular Risk in Individuals on Blood Pressure–Lowering Treatment

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 4, Iss. 11, 2015-11 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Telmisartan and Stroke Reduction in the ONTARGET Trial: Benefit beyond Blood Pressure Lowering?

By  

Cerebrovascular Diseases, Vol. 26, Iss. 5, 2008-10 ,pp. : 563-564

Karger

Access to resources Recommend Favorite

Blood Pressure-Lowering Efficacy of Amiloride versus Enalapril as Add-On Drugs in Patients with Uncontrolled Blood Pressure Receiving Hydrochlorothiazide

By Guerrero Patricia   Fuchs Flavio   Moreira Leila   Martins Vitor   Bertoluci Carolina   Fuchs Sandra   Gus Miguel  

Clinical and Experimental Hypertension, Vol. 30, Iss. 7, 2008-10 ,pp. : 553-564

Informa Healthcare

Access to resources Recommend Favorite